MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $926,000 | -71.5% | 5,406 | -63.5% | 0.02% | -71.6% |
| Q4 2020 | $3,251,000 | +328.3% | 14,802 | +223.8% | 0.07% | +155.2% |
| Q3 2020 | $759,000 | -59.6% | 4,572 | -72.2% | 0.03% | -69.5% |
| Q2 2020 | $1,878,000 | -35.2% | 16,450 | -26.9% | 0.10% | -28.0% |
| Q4 2019 | $2,899,000 | +80.1% | 22,500 | +8.9% | 0.13% | +26.9% |
| Q3 2019 | $1,610,000 | +126.4% | 20,660 | +199.4% | 0.10% | +14.3% |
| Q2 2019 | $711,000 | – | 6,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |